The COVID-19 pandemic has now strengthened its hold on human health and coronavirus'
lethal existence does not seem to be going away soon. In this regard, the optimization of …

Starting from late 2019, the coronavirus disease 2019 (COVID-19) has emerged as a once-
in-a-century pandemic with deadly consequences, which urgently calls for new treatments …

Antiviral drug therapy against SARS-CoV-2 is not yet established and posing a serious
global health issue. Remdesivir is the first antiviral compound approved by the US FDA for …

RNA dependent RNA polymerase (RdRp), is an essential in the RNA replication within the
life cycle of the severely acute respiratory coronavirus-2 (SARS-CoV-2), causing the deadly …

COVID-19 has recently caused a global health crisis and an effective interventional therapy
is urgently needed. Remdesivir is one effective inhibitor for SARS-CoV-2 viral RNA …

The RNA-dependent RNA polymerase (RdRp) is a key enzyme which regulates the viral
replication of SARS-CoV-2. Remdesivir (RDV) is clinically used drug which targets RdRp …

The efforts towards developing a potential drug against the current global pandemic, COVID-
19, have increased in the past few months. Drug development strategies to target the RNA …

Remdesivir is one nucleotide analogue prodrug capable to terminate RNA synthesis in
SARS-CoV-2 RNA-dependent RNA polymerase (RdRp) by two distinct mechanisms …

Remdesivir was the first antiviral drug that received emergency use authorization from the
United States Food and Drug Administration and is now formally approved to treat COVID …

The outbreak of a new coronavirus SARS-CoV-2 (severe acute respiratory syndrome–
coronavirus 2) has caused a global COVID-19 (coronavirus disease 2019) pandemic …